Skip to content
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Homepage
Open navigation
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Posts in: NCT
press clippings
perriman
NCT
Springwise case study: Unpacking how eXoZymes and Cayman Chemical are rethinking chemical manufacturing
April 17, 2026
press release
nutraceuticals
medicine
press clippings
video
science
podcast
perriman
NCT
eXoZymes CCO, Damien Perriman, outlines NCTx strategy and the commercial path for cell-free biomanufacturing on Grow Everything podcast
April 10, 2026
nutraceuticals
press clippings
NCT
Village Voice: The Metabolic Engine - How Scientists Are Exploring a New Path Beyond GLP-1 Weight-Loss Drugs
April 9, 2026
investor
nutraceuticals
medicine
press clippings
video
perriman
NCT
Nasdaq: Damien Perriman interview on NCT
April 2, 2026
investor
nutraceuticals
medicine
video
NCT
cannabinoids
Transcript: EXOZ investor update - 4Q + full year 2025 @ March 31, 2026
April 1, 2026
investor
nutraceuticals
medicine
perriman
NCT
EXOZ investor update: eXoZymes de-risks scale-up with Cayman Chemical, validating tech transfer with pharma-grade output
March 18, 2026
press release
nutraceuticals
medicine
video
perriman
NCT
Video interview: Successful pilot scale run with Cayman Chemical validates eXoZymes' technology and scalability
March 18, 2026
press release
nutraceuticals
medicine
perriman
NCT
eXoZymes’ CCO Damien Perriman to Present a NCT solution at next week’s MISTA Symposium
March 12, 2026
press release
investor
nutraceuticals
science
NCT
eXoZymes advancing commercial readiness with profound production metrics on initial NCT pilot run
January 29, 2026
heltzen
press release
investor
nutraceuticals
medicine
NCT
korman
eXoZymes achieves 100× scale-up of NCT production using exozymes, demonstrating near-perfect feedstock conversion
December 11, 2025
Previous page
Page 1 of 2
Next page